hCG beta Peptide Blocking Peptide peptide (STJ505377)
SPECIFICATIONS
ImmunogenSynthetic peptide taken within amino acid region 131-149 on human Chorionic gonaotropin beta protein.
General Information
| Short Description | hCG beta Peptide Blocking Peptide is synthetically produced from the 131-149 sequence and is suitable for use in western blot applications. |
| Applications | Immunodepletion/Immunocompetition |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Dilution Range | WB: IHC: 1:250ICC: 1:250IF: 1:250 |
| Formulation | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction | Store at-20ยฐC for long term storage. Avoid freeze-thaw cycles. |
Target Information
| Gene Symbol | CGB1 |
| Gene ID | 114335 |
| Uniprot ID | CGB1_HUMAN |
| Immunogen | Synthetic peptide taken within amino acid region 131-149 on human Chorionic gonaotropin beta protein. |
| Immunogen Region | 131-149 |
Additional Info
| Tissue Specificity | Expressed in placenta, testis and pituitary. |
| Peptide Name | Choriogonadotropin Subunit Beta Variant 1 |
| Cellular Localisation | Secreted |
| Alternative Peptide Names | Choriogonadotropin Subunit Beta Variant 1 proteinCGB1 protein |
Information sourced from Uniprot.org